Diabetologia

, Volume 57, Issue 5, pp 1084–1085

Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter]

Authors

    • Institute of Health & SocietyNewcastle University
  • Svetlana V. Glinianaia
    • Institute of Health & SocietyNewcastle University
  • Rudy W. Bilous
    • Institute of Cellular MedicineNewcastle University
    • James Cook University HospitalSouth Tees NHS Trust
  • Judith Rankin
    • Institute of Health & SocietyNewcastle University
    • Regional Maternity Survey OfficePublic Health England
  • Ruth Bell
    • Institute of Health & SocietyNewcastle University
    • Regional Maternity Survey OfficePublic Health England
Letter

DOI: 10.1007/s00125-014-3191-2

Cite this article as:
Tennant, P.W.G., Glinianaia, S.V., Bilous, R.W. et al. Diabetologia (2014) 57: 1084. doi:10.1007/s00125-014-3191-2

Keywords

ACE inhibitors Angiotensin II receptor antagonists HbA1c Hypertension Nephropathy Pregnancy

Abbreviations

ACEI

ACE inhibitor

ARB

Angiotensin II receptor blocker

Copyright information

© Springer-Verlag Berlin Heidelberg 2014